A 13-gene prognostic model developed using machine learning to predict the response to neoadjuvant chemoradiotherapy in rectal carcinoma - PubMed
4 hours ago
- #prognostic-model
- #machine-learning
- #rectal-carcinoma
- A 13-gene prognostic model was developed using machine learning to predict response to neoadjuvant chemoradiotherapy in rectal carcinoma.
- The study declares no competing interests among the authors.
- Key references include recent studies on cancer statistics, neoadjuvant therapy for rectal cancer, and ASCO guidelines.
- Funding sources include the National Science and Technology Major Project, National Natural Science Foundation of China, and various Tianjin-based grants.